Hypertension Diagnostics Inc

PINK:HDII USA Shell Companies
Market Cap
$0.98
Market Cap Rank
#51223 Global
#15897 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.19
About

Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marke… Read more

Hypertension Diagnostics Inc (HDII) - Total Assets

Latest total assets as of June 2021: $1.08 Million USD

Based on the latest financial reports, Hypertension Diagnostics Inc (HDII) holds total assets worth $1.08 Million USD as of June 2021.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Hypertension Diagnostics Inc - Total Assets Trend (1997–2021)

This chart illustrates how Hypertension Diagnostics Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Hypertension Diagnostics Inc - Asset Composition Analysis

Current Asset Composition (June 2021)

Hypertension Diagnostics Inc's total assets of $1.08 Million consist of 47.1% current assets and 52.9% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 8.0%
Accounts Receivable $191.85K 17.7%
Inventory $189.43K 17.5%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $0.00 0.0%
Goodwill $0.00 0.0%

Asset Composition Trend (1997–2021)

This chart illustrates how Hypertension Diagnostics Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Hypertension Diagnostics Inc's current assets represent 47.1% of total assets in 2021, a decrease from 81.3% in 1997.
  • Cash Position: Cash and equivalents constituted 8.0% of total assets in 2021, down from 75.0% in 1997.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1997.
  • Asset Diversification: The largest asset category is accounts receivable at 17.7% of total assets.

Hypertension Diagnostics Inc Competitors by Total Assets

Key competitors of Hypertension Diagnostics Inc based on total assets are shown below.

Hypertension Diagnostics Inc - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.49 - 3.51

Strong asset utilization - Hypertension Diagnostics Inc generates 3.51x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -87.30% - 304.51%

Excellent ROA - For every $100 in assets, Hypertension Diagnostics Inc generates $ 304.51 in net profit.

Hypertension Diagnostics Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.38 0.53 5.04
Quick Ratio 0.24 0.38 3.87
Cash Ratio 0.00 0.00 0.00
Working Capital $-834.51K $ -638.43K $ 997.59K

Hypertension Diagnostics Inc - Advanced Valuation Insights

This section examines the relationship between Hypertension Diagnostics Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio -
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 0.0%
Total Assets $1.08 Million
Market Capitalization $0.98 USD

Valuation Analysis

Below Book Valuation: The market values Hypertension Diagnostics Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Hypertension Diagnostics Inc's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Hypertension Diagnostics Inc (1997–2021)

The table below shows the annual total assets of Hypertension Diagnostics Inc from 1997 to 2021.

Year Total Assets Change
2021-06-30 $1.08 Million 0.00%
2020-12-31 $1.08 Million 0.00%
2020-06-30 $1.08 Million 0.00%
2019-12-31 $1.08 Million -27.36%
2017-12-31 $1.49 Million +6.19%
2016-12-31 $1.40 Million +7.39%
2012-12-31 $1.31 Million +1.54%
2011-06-30 $1.29 Million 0.00%
2010-12-31 $1.29 Million +24.52%
2009-06-30 $1.03 Million 0.00%
2008-12-31 $1.03 Million -48.88%
2007-12-31 $2.02 Million -13.88%
2006-12-31 $2.35 Million +6.93%
2005-12-31 $2.19 Million -2.23%
2004-12-31 $2.24 Million +94.29%
2003-12-31 $1.15 Million -73.18%
2002-12-31 $4.31 Million -25.94%
2001-12-31 $5.81 Million +0.48%
2000-12-31 $5.79 Million -33.49%
1999-12-31 $8.70 Million +443.75%
1997-12-31 $1.60 Million --